@jellyroll. Blood Glucose monitoring and Warfarin anti-coagulant monitoring are Old Hat. It is messy trying to get into an old market when your product isn't a magic advance. (Where is it now, newly, permitted? Is it India? Is there a small team in India, actually going round to Doctors??). They have Xprecia up and running Europe - what's the profit over cost of sales ? We don't get told.
I can't take Pet-tracker too seriously (it could be a help?). I mean, what do you do? Advertise in Veterinary Magazines??
At the other end, the intra-cellular molecular advances are suddenly so rapid and ultra-well funded by Big Pharma and Govt awards that it is pointless to put much into this. Yet there was $3.6M in R&D but $0.7M into marketing.
What are we left with? Sentia. I would have thought that was a possible winner and ahead of the other products.
Some more detailed reporting might alter my foreboding. (I have shares in another company which went up and up, I took too little profit before they crashed. It got a new super CEO and anyone can see how slack reporting had been misleading).
I'm interested in people's thoughts about direction because if there is a consensus we should remember we are shareholders not cheer-leaders.
- Forums
- ASX - By Stock
- UBI
- Ann: December 2023 Quarterly Activity Report and Appendix 4C
Ann: December 2023 Quarterly Activity Report and Appendix 4C, page-14
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UBI (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $40.23M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $230 | 1.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 273795 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 2050 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 236818 | 0.135 |
6 | 50371 | 0.130 |
3 | 18100 | 0.125 |
1 | 24004 | 0.120 |
1 | 26095 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 2050 | 2 |
0.150 | 50000 | 1 |
0.160 | 126368 | 4 |
0.165 | 22000 | 1 |
0.170 | 3366 | 1 |
Last trade - 10.29am 02/08/2024 (20 minute delay) ? |
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
UBI (ASX) Chart |